Molecular strategies to inhibit HIV-1 replication
Open Access
- 16 February 2005
- journal article
- review article
- Published by Springer Nature in Retrovirology
- Vol. 2 (1) , 10
- https://doi.org/10.1186/1742-4690-2-10
Abstract
The human immunodeficiency virus type 1 (HIV-1) is the primary cause of the acquired immunodeficiency syndrome (AIDS), which is a slow, progressive and degenerative disease of the human immune system. The pathogenesis of HIV-1 is complex and characterized by the interplay of both viral and host factors. An intense global research effort into understanding the individual steps of the viral replication cycle and the dynamics during an infection has inspired researchers in the development of a wide spectrum of antiviral strategies. Practically every stage in the viral life cycle and every viral gene product is a potential target. In addition, several strategies are targeting host proteins that play an essential role in the viral life cycle. This review summarizes the main genetic approaches taken in such antiviral strategies.Keywords
This publication has 92 references indexed in Scilit:
- Polyarginine Inhibits gp160 Processing by Furin and Suppresses Productive Human Immunodeficiency Virus Type 1 InfectionPublished by Elsevier ,2004
- Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpinsNucleic Acids Research, 2004
- RNA interference of HIV replicationTrends in Immunology, 2002
- Cloned zebrafish by nuclear transfer from long-term-cultured cellsNature Biotechnology, 2002
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by Template Analog Reverse Transcriptase Inhibitors Derived by SELEX (Systematic Evolution of Ligands by Exponential Enrichment)Journal of Virology, 2002
- Aromatic Polyamidines Inhibiting the Tat-Induced HIV-1 Transcription Recognize Structured TAR-RNAAntisense and Nucleic Acid Drug Development, 2001
- Amprenavir: A new human immunodeficiency virus type 1 protease inhibitorClinical Therapeutics, 2000
- Current develoments and future prospects for HIV gene therapy using interfering RNA-based strategiesFrontiers in Bioscience-Landmark, 2000
- Gene therapy for infectious diseases: the AIDS modelTrends in Genetics, 1994